Copyright
©The Author(s) 2024.
World J Clin Oncol. Mar 24, 2024; 15(3): 391-410
Published online Mar 24, 2024. doi: 10.5306/wjco.v15.i3.391
Published online Mar 24, 2024. doi: 10.5306/wjco.v15.i3.391
Figure 1 Flowchart for collecting and analyzing data from TCGA and METABRIC databases.
scRNA-seq: Single-cell RNA sequencing; TMB: Tumor mutation burden.
- Citation: Shi JY, Che X, Wen R, Hou SJ, Xi YJ, Feng YQ, Wang LX, Liu SJ, Lv WH, Zhang YF. Ferroptosis biomarkers predict tumor mutation burden's impact on prognosis in HER2-positive breast cancer. World J Clin Oncol 2024; 15(3): 391-410
- URL: https://www.wjgnet.com/2218-4333/full/v15/i3/391.htm
- DOI: https://dx.doi.org/10.5306/wjco.v15.i3.391